Results of intensive chemotherapy in 998
β
Hagop Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Stefan Faderl; Eli
π
Article
π
2006
π
John Wiley and Sons
π
English
β 146 KB
π 1 views
## Abstract ## BACKGROUND Elderly patients (age β₯ 65 years) with acute myeloid leukemia (AML) generally have a poor prognosis. AMLβtype therapy results are often derived from studies in younger patients and may not apply to elderly AML. Many investigators and oncologists advocate, at times, only s